Damien Tappy - Profile and Investment Details

Investor Profile

Damien Tappy is a Venture Capital, Private Equity Firm based in Switzerland with a diverse investment portfolio that includes companies such as OncoEthix, Medartis, IntelyCare, Venture Med Group, Amplidata, Endoart, Symetis, Hôpital de La Tour, Relievant Medsystems, Nfocus Neuromedical, PneumRx, Retailo, SmallRivers, BIND Therapeutics, VertiFlex, Rapid Micro Biosystems, Polares Medical, Kobojo, CXignited, EPFL Spin-Off & Start-up Program, ReShape Lifesciences, Chrono Therapeutics, CeQur, Gynesonics, Lumeon, Nuvaira, Lumavita, CommProve, SOPHiA GENETICS, V-Wave, Molecular Partners, EndoStim, Spartoo, Quid, . Over time, Damien Tappy has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Damien Tappy is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Patient Care, Health Care, Wearables, Hospitals, Genetics, Wellness, Women Founded, Apps, Healthcare Innovation, Life Science, Health Technology, Medical Technologies, Artificial Intelligence (AI), Information Technology (IT), Analytics, Diabetes, Finance, Bioinformatics, Software, Manufacturing, Biotechnology, Medical Devices, Genomics, Legal Tech, Clinical Trials, Employee Benefits, Consulting, Logistics, Social Impact, Digital Health, Medical, Big Data, Information Technology, B2B, Financial Advisory, Machine Learning, Pharmaceuticals, Healthcare Technology, Risk Management, Acquisitions may find it worthwhile to explore potential connections with Damien Tappy, as their portfolio suggests a familiarity and interest in this area.

Understanding Damien Tappy’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.